Evidence map›Paper›PMID 36457235›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2023

Amplification of Inflammation by Lubricin Deficiency Implicated in Incident, Erosive Gout Independent of Hyperuricemia.

Khaled Elsaid, Tony R Merriman, Leigh-Ana Rossitto, Ru Liu-Bryan, Jacob Karsh, Amanda Phipps-Green, Gregory D Jay, Sandy Elsayed, Marwa Qadri, Marin Miner and 12 more

Open access · hybridAbstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Lubricin's Mucin Domain Has Strong Polyproline Type II Helical Character.Computational and structural biotechnology journal · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. The Evolving Landscape of Gout in the Female: A Narrative Review.Gout, urate, and crystal deposition disease · 2023
    Article
  14. Review
  15. Review
  16. Article
  17. The inflammation process of gout arthritis and its treatment.Journal of advanced pharmaceutical technology & research
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 12 institutions in 7 countries.

Khaled ElsaidChapman University School of Pharmacy, Irvine, California.ORCID 0000-0002-8925-4255
Tony R MerrimanDivision of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, and Department of Biochemistry, University of Otago, Dunedin, New Zealand.ORCID 0000-0003-0844-8726
Leigh-Ana RossittoDepartment of Pharmacology, School of Medicine, and Skaggs School of Pharmacy and Pharmaceutical Sciences, UC San Diego, California.
Ru Liu-BryanVA San Diego Healthcare System, San Diego, and Department of Medicine, UC San Diego, La Jolla, California.ORCID 0000-0002-9611-8163
Jacob KarshThe Ottawa Hospital, Division of Rheumatology, University of Ottawa, Canada.
Amanda Phipps-GreenDepartment of Biochemistry, University of Otago, Dunedin, New Zealand.
Gregory D JayDepartment of Emergency Medicine, Alpert School of Medicine, and Division of Biomedical Engineering, School of Engineering, Brown University, Rhode, Island.
Sandy ElsayedChapman University School of Pharmacy, Irvine, California.
Marwa QadriJazan University, Jazan, Saudi Arabia.
Marin MinerVA San Diego Healthcare System, San Diego, California.
Murray CadzowDepartment of Biochemistry, University of Otago, Dunedin, New Zealand.
Talia J DambruosoDivision of Biomedical Engineering, School of Engineering, Brown University, Rhode, Island.
Tannin A SchmidtBiomedical Engineering Department, School of Dental Medicine, UConn Health, Farmington, Connecticut.
Nicola DalbethDepartment of Medicine, University of Auckland, Auckland, New Zealand.ORCID 0000-0003-4632-4476
Ashika ChhanaDepartment of Medicine, University of Auckland, Auckland, New Zealand.ORCID 0000-0001-7333-7024
Jennifer HöglundDepartment of Medical Biochemistry, Institute for Biomedicine, University of Gothenburg, Gothenburg, Sweden.
Majid GhassemianBiomolecular and Proteomics Mass Spectrometry Facility, Department of Chemistry/Biochemistry, UC San Diego.
Anaamika CampeauDepartment of Pharmacology, School of Medicine, and Skaggs School of Pharmacy and Pharmaceutical Sciences, UC San Diego, California.
Nancy MaltezThe Ottawa Hospital, Division of Rheumatology, University of Ottawa, Canada.ORCID 0000-0002-8535-4312
Niclas G KarlssonFaculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway, and Department of Medical Biochemistry, Institute for Biomedicine, University of Gothenburg, Gothenburg, Sweden.
David J GonzalezDepartment of Pharmacology, School of Medicine, and Skaggs School of Pharmacy and Pharmaceutical Sciences, Collaborative Center for Multiplexed Proteomics, Program for Integrative Omics and Data Science in Disease Prevention and Therapeutics, UC San Diego, La Jolla, California.
Robert TerkeltaubVA San Diego Healthcare System and Department of Medicine, UC San Diego.ORCID 0000-0001-5368-7473
University of California San Diego · USBrown University · USChapman University · USUniversity of Auckland · NZUniversity of Otago · NZUniversity of Ottawa · CAInstitute for Biomedicine · ITJazan University · SAUConn Health · USUniversity of Alabama at Birmingham · USUniversity of Oslo · NOVA San Diego Healthcare System · US

Funding

TISSUE ACQUISITION, MORPHOLOGY, AND CELL CULTUREP01AG007996 · NIA · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI LOTZ, MARTIN K · 1989 to 2016
$26.0M
GRADUATE TRAINING IN CELLULAR &MOLECULAR PHARMACOLOGYT32GM007752 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BROWN, JOAN HELLER, HANDEL, TRACY M · 1985 to 2023
$13.5M
The Effects of Urate Lowering Therapy on Inflammation, Endothelial function, andP50AR060772 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SINGH, JASVINDER A · 2012 to 2021
$12.8M
Rheumatic Diseases Research Training GrantT32AR064194 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GARY S FIRESTEIN, Monica Guma · 2013 to 2026
$3.8M
Non-tribologic Bioactivity of LubricinR01AR067748 · NIAMS · RHODE ISLAND HOSPITAL · PI ELSAID, KHALED AHMED, JAY, GREGORY D. · 2016 to 2020
$2.2M
Novel Synovial Role in Pathogenesis of GoutR21AR075990 · NIAMS · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI TERKELTAUB, ROBERT A. · 2019 to 2020
$333k
ATP-Citrate Lyase As A Novel Metabolic Target for OsteoarthritisI01BX002234 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI BRYAN, RU · 2015 to 2022
–
Intersections of matrix biology with inflammation in a new model of goutI01BX005927 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI TERKELTAUB, ROBERT A. · 2023 to 2023
–
BLRD VA I01 BX002234BLRD VA I01 BX005927NIAMS NIH HHS P50 AR060772NIAMS NIH HHS R01 AR067748NIAMS NIH HHS R21 AR075990NIAMS NIH HHS T32 AR064194NIA NIH HHS P01 AG007996NIGMS NIH HHS T32 GM007752
6 · The paper itself

Abstract

objectiveIn gout, hyperuricemia promotes urate crystal deposition, which stimulates the NLRP3 inflammasome and interleukin-1β (IL-1β)-mediated arthritis. Incident gout without background hyperuricemia is rarely reported. To identify hyperuricemia-independent mechanisms driving gout incidence and progression, we characterized erosive urate crystalline inflammatory arthritis in a young female patient with normouricemia diagnosed as having sufficient and weighted classification criteria for gout according to the American College of Rheumatology (ACR)/EULAR gout classification criteria (the proband).

methodsWe conducted whole-genome sequencing, quantitative proteomics, whole-blood RNA-sequencing analysis using serum samples from the proband. We used a mouse model of IL-1β-induced knee synovitis to characterize proband candidate genes, biomarkers, and pathogenic mechanisms of gout.

resultsLubricin level was attenuated in human proband serum and associated with elevated acute-phase reactants and inflammatory whole-blood transcripts and transcriptional pathways. The proband had predicted damaging gene variants of NLRP3 and of inter-α trypsin inhibitor heavy chain 3, an inhibitor of lubricin-degrading cathepsin G. Changes in the proband's serum protein interactome network supported enhanced lubricin degradation, with cathepsin G activity increased relative to its inhibitors, SERPINB6 and thrombospondin 1. Activation of Toll-like receptor 2 (TLR-2) suppressed levels of lubricin mRNA and lubricin release in cultured human synovial fibroblasts (P < 0.01). Lubricin blunted urate crystal precipitation and IL-1β induction of xanthine oxidase and urate in cultured macrophages (P < 0.001). In lubricin-deficient mice, injection of IL-1β in knees increased xanthine oxidase-positive synovial resident M1 macrophages (P < 0.05).

conclusionOur findings linked normouricemic erosive gout to attenuated lubricin, with impaired control of cathepsin G activity, compounded by deleterious NLRP3 variants. Lubricin suppressed monosodium urate crystallization and blunted IL-1β-induced increases in xanthine oxidase and urate in macrophages. The collective activities of articular lubricin that could limit incident and erosive gouty arthritis independently of hyperuricemia are subject to disruption by inflammation, activated cathepsin G, and synovial fibroblast TLR-2 signaling.

Indexed as

Arthritis, GoutyGoutHyperuricemiaAnimalsCathepsin GFemaleHumansInflammationInterleukin-1betaMiceNLR Family, Pyrin Domain-Containing 3 ProteinProteoglycan 4Toll-Like Receptor 2Uric AcidXanthine OxidaseCathepsin GInterleukin-1betaNLR Family, Pyrin Domain-Containing 3 ProteinProteoglycan 4Toll-Like Receptor 2Uric AcidXanthine Oxidase

Identifiers

PMID36457235
PMCPMC10191887
OpenAlexW4310592546

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.